DrugDashboards

Omeprazole and Sodium Bicarbonate

omeprazole, sodium bicarbonate · OMEPRAZOLE 20 mg/1; SODIUM BICARBONATE 1680 mg/1 · Powder, For Suspension · Oral · Oceanside Pharmaceuticals

NDC 68682-0990-30 · 30 PACKET in 1 CARTON / 1 POWDER, FOR SUSPENSION in 1 PACKET · NDA AUTHORIZED GENERIC · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has fallen 32% in a year, to $7.05 per unit — and generics that get this cheap tend to get abandoned rather than defended. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$10.00$20.00Sep 2020Sep 2025$7.05
20 price points · per EA · last surveyed Sep 17, 2025Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$2,620.90
Reported to Texas DSHS · 2024 annual filing · Bausch Health US, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$5,273
12 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for omeprazole and sodium bicarbonate (other) in the next 90 days

sole-source market · price up 3% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA021636
TE code
Approval date
Jun 15, 2004
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · CompletedFeb 2, 2024
    Bausch Health Companies, Inc.Subpotent Drug: Out of specification for assay

Manufacturers of omeprazole, sodium bicarbonate (Powder, For Suspension)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackOMEPRAZOLE 20 mg/1; SODIUM BICARBONATE 1680 mg/1Jul 15, 2026Sep 2, 2026
Oceanside PharmaceuticalsOMEPRAZOLE 20 mg/1; SODIUM BICARBONATE 1680 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Omeprazole and Sodium Bicarbonate — NDC 68682-0990-30," retrieved September 3, 2026, https://drugdashboards.com/drug/68682099030.

Free to cite with attribution — see how the data is put together.